EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma

Kecheng Qian, Xiaokai Cen, Yuhui Zhao, Ziqi Xuan, Zhaoxing Jia, Tianxiang Jiang, Congcong Ma, Zhong Di, Weiping Zhang, Xianming Lin

Biochemical Pharmacology · 2026-12 · 254 · 118552

DOI: 10.1016/j.bcp.2026.118552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026-12. Verfasst von Kecheng Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China. Die Arbeit nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains one of the most incurable malignancies, and systemic therapies continue to provide only limited clinical benefit despite encouraging preclinical evidence. Therapeutic failure has traditionally been attributed to insufficient drug efficacy or intrinsic resistance mechanisms. However, increasing evidence suggests that many conventional chemotherapeutic agents retain substantial antitumor activity but fail to achieve sufficient intratumoral exposure because of delivery barriers. This review proposes that inadequate drug delivery represents a major barrier limiting the therapeutic efficacy of conventional chemotherapeutics in GBM, independent of their intrinsic pharmacodynamic activity. We re-evaluate conventional chemotherapeutic agents, including alkylating agents, microtubule-targeting agents, topoisomerase inhibitors, and platinum compounds, from the perspective of blood-brain barrier (BBB) transport, heterogeneous intratumoral drug distribution, and dose-limiting systemic toxicity. We further discuss how emerging drug delivery strategies can restore the therapeutic potential of these agents by improving brain penetration and intratumoral distribution without altering their intrinsic pharmacological properties.By reframing chemotherapy failure in GBM as a consequence of both pharmacodynamic resistance and inadequate drug delivery, this Review highlights drug delivery as an underappreciated determinant of therapeutic efficacy.

Schlagwörter

Stichwörter der Autor:innen

Blood-Brain BarrierChemotherapy ResistanceDrug DeliveryGlioblastoma

Autor:innen und Institutionen

  • The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.
  • The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China; The Third Affiliated Hospital of Zhejiang, Chinese Medical University, H…
  • The Third Affiliated Hospital of Zhejiang, Chinese Medical University, Hangzhou, Zhejiang, 310005, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qian, K., Cen, X., Zhao, Y., Xuan, Z., Jia, Z., Jiang, T., Ma, C., Di, Z., Zhang, W., & Lin, X. (2026). Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma. Biochemical Pharmacology, 254, 118552. https://doi.org/10.1016/j.bcp.2026.118552

Vancouver

Qian K, Cen X, Zhao Y, Xuan Z, Jia Z, Jiang T, et al. Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma. Biochemical Pharmacology. 2026;254:118552. doi:10.1016/j.bcp.2026.118552

BibTeX
@article{Qian2026,
  author = {Qian, Kecheng and Cen, Xiaokai and Zhao, Yuhui and Xuan, Ziqi and Jia, Zhaoxing and Jiang, Tianxiang and Ma, Congcong and Di, Zhong and Zhang, Weiping and Lin, Xianming},
  title = {Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {254},
  pages = {118552},
  doi = {10.1016/j.bcp.2026.118552}
}
Kostenlos starten →